PT Pyridam Farma Tbk (IDX:PYFA) and PT Pyfa Sehat Indonesia entered into an agreement to acquire PT Ethica Industri Pharmaceutical from Fresenius Kabi Aktiengesellschaft and Fresenius Kabi Deutschland Gmbh for IDR 163.4 billion on May 30, 2022. he company said it would buy 41.93 million series B shares and 7.4 million series A shares. The company will seek approval from shareholders at the Extraordinary General Meeting of Shareholders (EGMS) regarding this acquisition plan on Wednesday (20/7). Ernst &Young Advisory Services acted as financial advisors to Fresenius Kabi.